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Increased b-cell sensitivity to glucose precedes the loss
of glucose-induced insulin secretion in diabetic animals.
Changes at the level of b-cell glucose sensor have been
described in these situations, but it is not clear whether
they fully account for the increased insulin secretion.
Using a euglycemic-normolipidemic 60% pancreatec-
tomized (60%-Px) mouse model, we have studied the
ionic mechanisms responsible for increased b-cell glu-
cose sensitivity. Two weeks after Px (Px14 group), Px
mice maintained normoglycemia with a reduced b- c e l l
mass (0.88 ± 0.18 mg) compared with control mice 
(1.41 ± 0.21 mg). At this stage, the dose-response curve
for glucose-induced insulin release showed a signific a n t
displacement to the left (P < 0.001). Islets from the
Px14 group showed oscillatory electrical activity and
cytosolic Ca2 + ( [ C a2 +]i) oscillations in response to glu-
cose concentrations of 5.6 mmol/l compared with islets
from the control group at 11.1 mmol/l. All the above
changes were fully reversible both in vitro (after 48-h
culture of islets from the Px14 group) and in vivo (after
regeneration of b-cell mass in islets studied 60 days
after Px). No significant differences in the input resis-
tance and ATP inhibition of ATP-sensitive K+ ( KAT P)
channels were found between b-cells from the Px14 and
control groups. The dose-response curve for glucose-
induced MTT (C,N- d i p h e n y l - N9 9-4,5-dimethyl thiazol 2 yl
tetrazolium bromide) reduction showed a significant
displacement to the left in islets from the Px14 group 
(P < 0.001). These results indicate that increased glu-
cose sensitivity in terms of insulin secretion and Ca2 + s i g-
naling was not due to intrinsic modifications of KAT P
channel properties, and suggest that the changes are
most likely to be found in the glucose metabolism.
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B
lood glucose level is maintained within a narrow
range through a mechanism coupling changes in
extracellular glucose concentrations to insulin
secretion (1,2). With hyperglycemia, increased
glucose metabolism raises the ATP/ADP ratio, which
closes ATP-sensitive K+ ( KAT P) channels (3); the subsequent
depolarization causes bursts of electrical activity (4), cyto-
solic Ca2 + ( [ C a2 +]i) oscillations (5), and insulin release (6).
Chronic hyperglycemia, however, results in impaired glu-
cose-induced insulin secretion, a defect that has been con-
sidered to play a major role in the pathogenesis of type 2
diabetes (7). Recently, it has been shown that a raised sen-
sitivity to glucose precedes the loss of glucose-induced
insulin secretion in hyperglycemic rats (8). However,
hyperglycemia did not appear to be the cause of the height-
ened b-cell sensitivity to glucose that has also been
described in different normoglycemic conditions such as
partial pancreatectomy (8), insulin resistance (9), glucose
infusion (10), or normal pregnancy (11). A common feature
of these normoglycemic conditions with enhanced glu-
cose-stimulated insulin secretion is the increased work-
load placed on b-cells, suggesting that the rise in glucose
sensitivity represents an adaptive response of the b-cells to
an increased demand for insulin. Changes at the level of 
the b-cell glucose sensor, the glucose-phosphorylating
enzymes glucokinase and hexokinase (12,13), and the b- c e l l
glucose transporter GLUT2 (14) have been described in
situations of b-cell hyperfunction. It is not clear, however,
whether these changes fully account for the increased
insulin secretion.
We recently reported an increased glucose sensitivity in
transplanted islets when normoglycemia was restored in
diabetic recipients through the transplantation of a limited
b-cell mass. In this model, increased sensitivity was attrib-
uted to a resting decrease in the fraction of blockable KAT P
channels in transplanted b-cells (15). However, these mice
were hyperglycemic for 1 week after transplantation, and
therefore the influence of previous hyperglycemia on
changes in glucose sensitivity could not be completely ruled
out. The aim of the present study was to determine the ionic
mechanisms responsible for b-cell increased glucose sensi-
t i v i t y. The 60% pancreatectomy (Px) model was chosen
because it is known that after 60% Px, normoglycemia is
maintained despite the reduced b-cell mass, thus excluding
the effects of hyperglycemia (8).
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AM, acetoxymethyl derivative; [Ca2 +]i, cytosolic Ca
2 +; FFA, free fatty acid;
I P G T T, intraperitoneal glucose tolerance test; KAT P, ATP-sensitive K
+; KRBB,
Krebs-Ringer bicarbonate buffer; MTT, C,N- d i p h e n y l - N9 9-4,5-dimethyl thiazol
2 yl tetrazolium bromide; Px, pancreatectomy; RIA, radioimmunoassay.
DIABETES, VOL. 48, OCTOBER 1999 1955
F. MARTÍN AND ASSOCIATES
RESEARCH DESIGN AND METHODS
Partial pancreatectomy model.60% Px was performed on 8- to 12-week-old male
C57B1/6 mice (B&K Universal, North Humberside, U.K.) using the method
described previously in rats (16). After an overnight fast, mice were anesthetized
by intraperitoneal injection of 50 mg/kg barbital sodium (Normon Laboratory,
Madrid), 90 mg/kg ketamine (Parke-Davis S.L., Barcelona), 0.8 mg/kg atropine
(Braun Medical S.A., Jaen, Spain), and 4 mg/kg diazepam (Roche S.A., Madrid). After
midline abdominal incision, the splenic lobe of the pancreas was mobilized by par-
tially breaking the mesenteric connections to the stomach, small bowel, and
retroperitoneum. Pancreatic tissue was removed by gentle abrasion with cotton
applicators, with care being taken to leave major blood vessels intact. The excised
portion included the splenic lobe of the pancreas but not the small flap attached
to the pylorus. To establish the 60% Px in mice, in a set of preliminary experiments
the pancreatic remnant was excised and weighed immediately after the partial pan-
c r e a t e c t o m y. The weight was compared with that of normal pancreas of control
(nonpancreatectomized) mice of similar age and weight. The extent of pancrea-
tectomy was modified until the weight of the pancreatic remnant was 40% of nor-
mal pancreas. Control mice (shams) underwent laparotomy and mobilization of
the pancreas. Body weight, nonfasting blood glucose concentrations, and plasma
free fatty acids (FFAs) were measured at between 9 and 11 A.M. on the day of surgery
and days 5, 7, 10, 14, 30, 45, and 60 after Px. An intraperitoneal glucose tolerance
test (IPGTT) was performed in four control mice, four mice 14 days after 60% Px,
and five mice 60 days after 60% Px. After overnight fasting, blood samples (20 µl)
were obtained by tail snip before (0 min) and 15, 30, 60, and 120 min after an
intraperitoneal injection of glucose (1 g/kg). Blood glucose was obtained from the
snipped tail and measured with a portable glucose meter (Accutrend GC;
Boehringer Mannheim, Mannheim, Germany). FFAs were assayed using a kit from
Boehringer Mannheim.
Four groups of mice were studied: 1) Px14 group (mice studied 14 days after
60% Px) (n = 30); 2) Px60 group (mice studied 60 days after 60% Px) (n = 14); 
3) control14 group (sham-Px mice of similar body weight to Px14 mice) (n = 12); and
4) control60 group (sham-Px mice of similar body weight to Px60 mice) (n = 8).
Islet isolation, cell isolation, and culture. Islets of Langerhans were iso-
lated as previously described (17). Briefly, after pancreas digestion with col-
lagenase (Collagenase A; Boehringer Mannheim) in a stationary bath at 37°C, islets
were separated by centrifugation and hand-picked under a stereomicroscope. Once
isolated, islets were dissociated into single cells in a low-calcium medium as pre-
viously described (18). Cells were then centrifuged, resuspended in culture
medium (RPMI 1640 supplemented with 10% fetal calf serum, 100 IU/ml penicillin,
0.1 mg/ml streptomycin, and 5.6 mmol/l glucose), and plated on glass coverslips.
Cells were kept at 37°C in a humidified atmosphere of 95% O2, 5% CO2 and used
between 6–10 h of culture, to avoid reversibility of the changes. When indicated,
isolated islets were cultured during 48 h in the same medium and kept at 37°C in
a humidified atmosphere of 95% O2, 5% CO2. For intracellular recording experi-
ments, islets were isolated by microdissection as previously described (19).
E l e c t r o p h y s i o l o g y
Patch clamp experiments. Patch pipettes were pulled from Clark Elec-
tromedical glass capillaries (Reading, U.K.) using a two-stage puller (Mecanex BB-
CH, Geneva), with resistances in the range of 3–12 MV when filled with a stan-
dard solution (values in mmol/l): 5 KCl, 135 NaCl, 10 HEPES, 2.5 CaCl2, and 1.1
M g C l2, pH 7.4. Bath solution contained (in mmol/l) 140 KCl, 1 CaCl2, 1 MgCl2, 10
HEPES, and 1 EGTA, pH 7.2. Solutions containing ATP (Sigma, St. Louis, MO) were
applied through an RSC-100 rapid solution changer (Biologic, Claix, France).
KAT P channel unitary currents were registered from excised membrane patches
in the inside-out configuration (20). Currents were measured using an Axopatch
200 amplifier (Axon Instruments, Foster City, CA) and stored in a tape recorder
( D AT, DTR-1202; Biologic) for subsequent analysis with a homemade program.
Experiments were replayed through an eight-pole Bessel filter (Frequency
Devices, Haverhill, MA) at 1 kHz and sampled at 10 kHz. Pipette potential was held
at 0 mV throughout the record. The experiments were carried out at room tem-
perature (20–24°C). Dose-response curves were obtained by integrating the area
corresponding to channel activity in the presence of different ATP concentrations
(2.5, 5, 10, 20, 40, and 2,000 µmol/l) and fitting these data to the Hill equation.
Intracellular record i n g . Membrane potential of the b-cell was recorded as
described (19). Microdissected islets were fixed with micropins to the bottom
of a 50-µl chamber and perifused at a rate of 0.8 ml/min with fresh modified Krebs
medium and constantly gassed with a mixture of O2 (95%) and CO2 (5%) for a  fin a l
pH of 7.4. Different glucose concentrations (0, 5.6, 11.1, 16.7, and 22.2 mmol/l)
were added to the superfusion medium. The test agents reached the chamber
with a delay of 3 s. These delays have been corrected for in the figures. Bath tem-
perature was maintained at 36 ± 1°C by a peltier controlled by a thermostat. The
temperature of the chamber was continuously monitored with a microthermis-
t o r. Recordings were made with an Axoclamp 2B amplifier (Axon Instruments).
Data acquisition was performed with Axotape version 2.0 (Axon Instruments)
and data analysis with MicroCal Origin version 3.7 (MicroCal Software,
Northampton, MA).
[ C a2 +]i m e a s u r e m e n t
Indo-1 loading. Collagenase-isolated islets were incubated for 1 h at 37°C in mod-
i fied Krebs medium supplemented with 5.6 mmol/l glucose and 3% bovine serum
albumin. The medium was continuously bubbled with a mixture of O2 (95%) and
C O2 (5%) for a final pH of 7.4. Islets were loaded as described (21). Islets were
loaded with Indo-1 (Molecular Probes, Eugene, OR) by incubation for 1 h at
room temperature in the described medium with 2 µmol/l of the acetoxymethyl
derivative (AM). Indo-1 AM was added as a concentration stock solution in DMSO
(Sigma) (final DMSO concentration 0.3% vol/vol). To facilitate the solubilization
of Indo-1/AM in physiologic media, the mixture also contained 10% (wt/wt) of the
nonionic surfactant polyol pluronic F127 (Molecular Probes). After loading, islets
were incubated with a modified Krebs medium supplemented with 1% bovine
serum albumin. The Krebs medium was kept at 37°C and was constantly gassed
with a mixture of O2 (95%) and CO2 (5%) for a final pH of 7.4.
Superfusion of islets. Each islet was then transferred to an open chamber 
(300 µl volume) mounted on the stage of an epifluorescence Nikon-Diaphot
inverted microscope (Nikon, Tokyo). Islets of similar, medium size (100–200 µm
diameter) were used for all experiments. Individual islets were left to settle down
in the chamber for 1–2 min in the absence of perfusion. Islets usually remained
attached to the glass bottom of the chamber during a perfusion experiment.
Islets were superfused at a rate of 0.5 ml/min with fresh modified Krebs medium
supplemented with 1% bovine serum albumin and constantly gassed with a mix-
ture of O2 (95%) and CO2 (5%) for a final pH of 7.4. Different glucose concentra-
tions (3, 5.6, 11.1, and 16.7 mmol/l) were added to the superfusion medium. The
test agents reached the chamber with a delay of 15 s. These delays have been cor-
rected for in the figures. Bath temperature was maintained at 36 ± 1°C by heat-
ing a stainless steel ring controlled by a thermostat. The temperature of the
chamber was continuously monitored with a microthermistor.
Measurements of [Ca2 +]i. [ C a
2 +]i was monitored as described (21) by measur-
ing the fluorescence emitted by Indo-1. Indo-1 was excited at 350 ± 5 nm by
means of a 100 W mercury lamp. The level of ultraviolet excitation light compatible
with a good signal-to-noise ratio was adjusted by placing neutral-density filters in
the light pathway to reduce photobleaching and photodamage of the preparation.
The emitted fluorescence was split into two beams with a dichroic mirror (450 nm),
filtered at 410 ± 5 and 480 ± 5 nm, respectively, and detected by two photomulti-
pliers (Thorn EMI 9924B; Middlesex, U.K.). An increase in [Ca2 +]i produces a rise
in Indo-1 fluorescence at 410 nm; conversely, a fluorescence decrease is observed
at 480 nm (22). The fluorescence ratio (F4 1 0/ F4 8 0) was determined online and 
filtered at 10 kHz. [Ca2 +]i was estimated using the equation proposed by
Grynkiewicz et al. (22). Autofluorescence levels were measured from control islets
and found to be <15% of the total flu o r e s c e n c e .
Insulin measurements. Insulin measurements were performed as described (23).
B r i e fly, collagenase-isolated islets were incubated for 1 h at 37°C in modified Krebs
medium supplemented with 5.6 mmol/l glucose and 3% bovine serum albumin. The
medium was continuously bubbled with a mixture of O2 (95%) and CO2 (5%) for
a final pH of 7.4. For static incubations, islets were incubated in groups of three
in 1 ml fresh modified Krebs buffer with 1% bovine serum albumin plus the dif-
ferent glucose concentrations (2.8, 4.2, 5.6, 8.3, 11.1, 16.7, and 22.2 mmol/l) for 
30 min at 37°C. For perifusion experiments, batches of 10 islets were placed in a
50-µl chamber and perifused at a flow rate of 1 ml/min at 37°C. The islets were fir s t
perifused in 3 mmol/l glucose for 30 min to reach a state of stable insulin release.
The solutions were prewarmed at 37°C and continuously gassed. Throughout the
perifusion, effluent was continuously collected at 2-min intervals. The dead time
was 2 min and has been corrected for in the figures. Both static incubation and
perifused samples were kept at –20°C until insulin determination. For measure-
ment of insulin content, the medium was removed and islets were washed three
times in 1 ml fresh modified Krebs-Ringer bicarbonate buffer (KRBB) supple-
mented with 2.8 mmol/l glucose and without BSA. Afterward, islets were sonicated
15 s 3 3 at maximum power (model W-225; Heat Systems-Ultrasonic, Farming-
dale, NY) in 100 µl of 1:10 acid-ethanol mixture (95% ethanol, 750 ml; concentrated
HCl, 15 ml; H2O, 235 ml). A 50-µl portion of each sample was kept at –20°C until
insulin determination. In addition, aliquots of 15 µl of the same samples were stored
at –80°C for protein determination. Protein content was measured by Bradford
a s s a y. Samples were done in triplicate at each point. Insulin was assayed by radioim-
munoassay (RIA) using a kit from DPC (Los Angeles). The RIA included the following
steps: addition of anti-porcine insulin guinea pig serum, incubation for 36 h at 4°C,
addition of freshly labeled [1 2 5I](TYR A19)-human insulin, incubation for 18 h at 4°C,
and precipitation of bound insulin by ethanol. Rat insulin was used to prepare the
standard curves. Standard curves and problems were run in triplicate.
b-Cell mass measurement. Each mouse was anesthetized, and the pancreas
(control groups) or pancreatic remnants (Px14 and Px60 groups) were excised,
blotted, weighed, fixed in Bouin’s solution, and embedded in paraffin. The weight
of the pancreatic tissue was determined on a Mettler A240 balance (Metler Instru-
ment, Hightstown, NJ), reading to 0.01 mg, as described (24,25). Sections of pan-
creas were stained with immunoperoxidase for the endocrine non–b-cells of the
islets (15). Immunostaining used a cocktail of antibodies (Dako, Carpinteria, CA):
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rabbit anti-porcine glucagon (final dilution 1:1,000), rabbit anti-human somatostatin
( final dilution 1:1,000), and rabbit anti-human pancreatic polypeptide (final dilu-
tion 1:500). A swine anti-rabbit IgG was used as a secondary antibody. b-Cell mass
was measured by point-counting morphometry (25). Each immunoperoxidase-
stained section was covered systematically using a 48-point grid to obtain the num-
ber of intercepts over b-cells, endocrine non–b-cells, and other tissue. The b- c e l l
relative volume was calculated by dividing the intercepts over b-cells by intercepts
over total tissue; then the b-cell mass was estimated by multiplying b-cell relative
volume by pancreas weight.
MTT assay. Collagenase-isolated islets were incubated for 1 h at 37°C in modifie d
Krebs medium supplemented with 5.6 mmol/l glucose and 3% bovine serum albu-
min. The medium was continuously bubbled with a mixture of O2 (95%) and CO2
(5%) for a final pH of 7.4. Then, MTT (C,N- d i p h e n y l - N9 9-4,5-dimethyl thiazol 2 yl tetra-
zolium bromide) reduction was measured as previously described (26). Batches
of 15 islets were incubated in 1 ml fresh modified KRBB with 1% bovine serum albu-
min, 0.5 mg/ml MTT (Sigma), and the different glucose concentrations (2.8, 4.2, 5.6,
8.3, 11.1, 16.7, and 22.2 mmol/l) for 30 min at 37°C. This incubation time was
selected because formazan production had reached a plateau. To solubilize the for-
mazan crystals at the end of the incubation periods, the medium was removed and
islets were washed three times in 1 ml fresh modified KRB buffer supplemented
with 2.8 mmol/l glucose and without BSA. Afterward, islets were sonicated 15 s 3
3 at maximum power (model W-225; Heat Systems-Ultrasonic) in 100 µl iso-
propanol. The optical density was recorded with an automatic U-2000 spec-
trophotometer at 540 nm (Hitachi, Tokyo). Aliquots (15 µl) of islet extracts were
stored at –80°C for protein determination. Protein content was measured by Brad-
ford assay. Samples were done in triplicate at each glucose concentration.
Statistical analysis. Patch clamp results were expressed as means ± SD. For
comparisons between two groups, the unpaired We l c h ’s t test (two-tailed) was
used. The rest of the results were expressed as means ± SE. Statistical differences
in the dose-response curves were tested using the test of comparison of experi-
mental curves. P < 0.05 was considered signific a n t .
R E S U LT S
Metabolic evolution and b-cell mass. N o r m o g l y c e m i a
and normolipidemia were maintained in all the mice after 60%
Px (Table 1). Postprandial mild hyperglycemia was excluded,
because blood glucose was always determined in fed animals.
In addition, blood glucose values after IPGTT were similar in
mice from control14, Px14, and Px60 groups (Fig. 1). 
After 60% Px, b-cell mass increased progressively in Px14 and
Px60 groups. Fourteen days after Px, b-cell mass in the pan-
creatic remnant was 62.5% of b-cell mass in control14 group,
and by day 60 it had increased to 93.6% of the initial b-cell mass
(control14 group) and 79.0% of the b-cell mass in weight-
matched controls (control60 group). In contrast, the endocrine
n o n –b-cell mass increased modestly; on day 60 after Px it was
60% of the initial non–b-cell mass (control14) and 53.4% of
weight-matched control (control60 group) (Table 1).
E ffect of pancreatectomy on glucose-induced insulin
s e c r e t i o n . The glucose-induced insulin secretion from islets
in control and Px14 groups is shown in Fig. 2. The relation-
ship between insulin secretion and glucose concentration
was sigmoidal in both groups; however, the dose-response
curve in islets from Px14 group showed a significant dis-
placement to the left in the dose response (EC5 0 = 7.46 ±
0.27 mmol/l) when compared with islets from control14
group (EC5 0 = 10.24 ± 0.08 mmol/l) (F(2, 56) = 11.76; P < 0.001).
A broader glucose response range and a reduced glucose
threshold for insulin secretion were seen in Px14 (Fig. 2A) .
Islets from Px14, when compared with the control14 group,
showed increased insulin secretion in response to lower glu-
cose concentrations (5.6 and 8.3 mmol/l glucose, respec-
tively). Islets from Px14 group recovered a normal glucose-
induced insulin secretion after 48-h culture in 5.6 mmol/l glu-
cose (Fig. 2A). In addition, at any glucose concentration >5.6
mmol/l, islets from the Px14 group showed a higher insulin
release than control14 group islets (P < 0.001) (Fig. 2A) .
Insulin content in islets from control14, Px14, and 48 h–cul-
tured Px14 groups were similar (19.09 ± 1.56, 17.76 ± 1.25, and
20.31 ± 2.29 ng/µg protein, respectively; 15 islets from 4 mice
in control14 and Px14 groups and 8 islets from 3 mice in 48 h–
cultured Px14 group). Finally, protein content in islets from
control14 and Px14 groups was also similar (2.72 ± 0.19 and
2.99 ± 0.34 µg protein/islet, respectively; 15 islets from 4 mice
in both groups).
Perfused mouse islets responded to a stepwise increase in
glucose concentration with a rapid and transient burst of
insulin secretion (first phase) followed by a plateau (second
TABLE 1
Characteristics of experimental groups
Blood glucose N o n –b- c e l l
G r o u p Body weight (g) ( m m o l / l ) b-Cell mass (mg) mass (mg)
Control14 (n = 5) 33.5 ± 0.9 6.4 ± 0.3 1.41 ± 0.21 0.25 ± 0.05
Px14 (n = 6)
Day 5 6.4 ± 0.1
Day 7 6.2 ± 0.1
Day 10 6.6 ± 0.2
Day 14 33.9 ± 0.9 7.7 ± 0.2 0.88 ± 0.18* 0.12 ± 0.05*
Px60 (n = 6) 42.9 ± 1.2 7.1 ± 0.5 1.32 ± 0.15 0.15 ± 0.04*
Control60 (n = 6) 41.4 ± 0.9 6.7 ± 0.2 1.67 ± 0.33 0.28 ± 0.04
Data are means ± SE. *P < 0.001 compared with control.
FIG. 1. Effect of pancreatectomy on glucose tolerance in control14 (s)
(n = 4), Px14 (d) (n = 4), and Px60 (j) (n = 5) groups. Results are
expressed as means ± SE.
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phase) which lasted as long as glucose was present. Insulin
release from Px14 islets increased significantly (P < 0.001)
compared with control14 group islets (Fig. 2B) .
E ffect of pancreatectomy on membrane potential and
[ C a2 +]i. The glucose-induced electrical activity in b- c e l l s
from control14 and Px14 islets is summarized in Fig. 3. In the
Px14 group, b-cells (8 from 8 islets in 6 mice) showed an
increased glucose sensitivity (Fig. 3B) compared with b- c e l l s
from control14 group islets (Fig. 3A) (7 b-cells from 7 islets
in 4 mice). b-Cells from the Px14 group showed oscillatory
electrical activity at glucose concentrations (5.6 mmol/l)
(Fig. 3B) lower than in b-cells from the control14 group 
(11.1 mmol/l) (Fig. 3A). Furthermore, the pattern of response
in control14 group b-cells elicited with maximal glucose con-
centrations (22 mmol/l) (data not shown) was achieved in 
b-cells from the Px14 group with 16.7 mmol/l glucose (Fig. 3B) .
In contrast, no significant differences were found in the 
electrical activity of b-cells from control and Px60 groups 
(12 b-cells from 12 islets in 4 mice) (data not shown). When
the parameters studied (fraction of time in active phase)
were plotted as a function of glucose concentrations, the
dose-response curve in b-cells from Px14 group was found to
be shifted left compared with b-cells from control14 and
Px60 groups (Fig. 3B). Values for the input resistance in b- c e l l s
from control14 and Px14 groups were similar under non-
FIG. 2. Effect of pancreatectomy on glucose-induced insulin secretion.
A: Islets from control14 (s), Px14 (d), and Px14 cultured 48 h in 
5.6 mmol/l glucose (m) groups were incubated in batches of three for 
30 min at 37°C in 1 ml fresh modified KRBB with 1% bovine serum albu-
min plus different glucose concentrations. Values are expressed as
means ± SE of eight experiments. *P < 0.05 compared with control
group. B: Batches of 10 islets from control14 (s) and Px14 (d)
groups were perfused at a flow rate of 1 ml/min at 37°C. After a 
30-min stabilization with 3 mmol/l glucose, the islets were perfused for
10 min with 3 mmol/l glucose, then for 20 min with 22 mmol/l glucose
(as indicated by the bar), and finally for 10 min with 3 mmol/l glucose.
The perfusion medium was fresh modified KRBB with 1% bovine
serum albumin alone. Insulin was assayed by RIA, and d e t e r m i n a t i o n s
were run in triplicate. Values are expressed as means ± SE of six exper-




FIG. 3. Glucose-induced electrical activity in islets from pancreatec-
tomized mice. A: Representative examples of the effects of diff e r e n t
glucose concentrations (5.6, 11.1, and 16.7 mmol/l) on intracellularly
recorded membrane potential of a pancreatic b-cell in the intact islet.
B: Fraction of time in the active phase in control14 (s), Px14 (d), and
Px60 (n) islet b-cells. In control14, Px14, and Px60 groups, the same
islet was perfused with different glucose concentrations. G, glucose.
*P < 0.05 compared with control14 group.
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stimulatory (180 ± 30 and 150 ± 20 MV, respectively) and stim-
ulatory (235 ± 35 and 220 ± 35 MV, respectively) glucose
c o n c e n t r a t i o n s .
[ C a2 +]i responses to glucose are shown in Fig. 4. Islets from
the Px14 group showed [Ca2 +]i oscillations in response to
lower glucose concentrations (5.6 mmol/l) (Fig. 4B) than
control14 group islets (11.1 mmol/l) (Fig. 4A). In the presence
of 11.1 mmol/l glucose, [Ca2 +]i oscillations in Px14 group
were broader in duration (121.1 ± 10.3 s, P < 0.001; 12 islets
from 5 mice) (Fig. 4B) compared with islets from the control14
group (20.7 ± 1.7 s; 17 islets from 5 mice) (Fig. 4A). In addition,
the pattern of response in islets from control14 group elicited
with maximal glucose concentrations (22 mmol/l) (data not
shown) was achieved in Px14 islets with 16.7 mmol/l glu-
cose (Fig. 4B). In contrast, no significant differences were
found in [Ca2 +]i in islets from the Px60 group (7 islets from 
4 mice) compared with islets from the control14 group (data
not shown).
Islets from the Px14 group recovered their normal glucose-
induced [Ca2 +]i oscillatory pattern after 48-h culture (Fig. 5).
As in islets from the control14 group, 48 h–cultured Px14
islets did not exhibit any [Ca2 +]i oscillatory behavior in
response to 5.6 mmol/l glucose (12 islets from 3 mice) (Fig. 5B)
and elicited 11.1 mmol/l glucose–induced regular [Ca2 +]i
oscillations (Fig. 5C). Of note, 48-h culture in 5.6 mmol/l glu-
cose did not significantly affect glucose-induced insulin
release in control islets (data not shown). There were no
s i g n i ficant differences between the [Ca2 +]i levels (10 min of
register): 339.8 ± 31.3 nmol/l in control14 group islets perfused
with 11.1 mmol/l glucose (Fig. 4A); 367.5 ± 41.3 nmol/l in Px14
group islets perfused with 5.6 mmol/l glucose (Fig. 4B); 379.4 ±
52.8 nmol/l in Px14 group islets perfused with 5.6 mmol/l glu-
cose (Fig. 5A); and 402.7 ± 49.6 nmol/l in 48 h–cultured Px14
group islets perfused with 11.1 mmol/l glucose (Fig. 5C) .
E ffect of pancreatectomy on KAT P channel activity.
Figure 6 shows the dose-response relationship for the inhi-
bition of KAT P channel activity in the presence of different 
concentrations of ATP in b-cells from Px14 and control14
groups. The two representative current records (control 
and Px14) shown at the top illustrate the effects of 2.5 and 
40 µmol/l ATP on KAT P channel activity. Patches were initially
exposed to 2 mmol/l AT P, then to 0 mmol/l AT P, then to a test
ATP concentration. ATP (2 mmol/l) was applied after every
test to minimize rundown. The current in 2 mmol/l ATP was
FIG. 4. Glucose-induced [Ca2 +]i changes in
islets from pancreatectomized mice. Rep-
resentative examples of the effect of dif-
ferent glucose concentrations (5.6, 11.1,
and 16.7 mmol/l) on [Ca2 +]i. In control14
and Px14 groups, the same islet was per-
fused with different glucose concentra-
tions. G, glucose.
FIG. 5. Recovery of glucose-induced [Ca2 +]i changes in islets from
pancreatectomized mice. A: Representative example of the effect of 
5.6 mmol/l glucose concentration on [Ca2 +]i in freshly isolated islets
from Px14 group. B: Representative example of the effect of 5.6 mmol/l
glucose concentration on [Ca2 +]i in 48 h–cultured islets from Px14
group. C: Representative example of the effect of 11.1 mmol/l glucose
concentration on [Ca2 +]i in 48 h–cultured islets from Px14 group.
Groups are described in M E T H O D S. G, glucose.
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taken as Ø current and subtracted from the current measured
in each test solution. Current in the absence of ATP was taken
as Im a x. The average current in each ATP exposure was
expressed as a fraction of Im a x. No significant differences for
ATP inhibition were found between b-cells from the Px14
and control14 groups. The data could be fitted to a Hill equa-
tion with an IC5 0 of 15.9 µmol/l and a Hill coefficient of 1.2 for
the Px14 group (n = 3) and an IC5 0 of 15.5 µmol/l and a Hill coef-
ficient of 0.9 for the control14 group (n = 3) (Fig. 6B). No signi-
ficant difference was observed in the unitary current between
b-cells from Px14 and control14 groups (data not shown).
MTT reduction. Both control14 and Px14 islets incubated
in the presence of MTT showed a sigmoidal increase in for-
mazan production as a function of increasing extracellular glu-
cose concentration, reaching a maximal value at 11.1 mmol/l
glucose (Fig. 7). However, a significant displacement to the
left in the dose-response curve was observed in Px14 islets
( E C5 0 = 7.14 ± 0.12 mmol/l) compared with control14 group
islets (EC5 0 = 9.76 ± 0.25 mmol/l) (F(2, 50) = 13.41; P < 0.001)
(Fig. 7). Additionally, there was a broadening in the glucose
response range through a reduction of the threshold to glu-
cose metabolism. Compared with basal values, MTT reduc-
tion in Px14 islets was increased at 5.6 mmol/l glucose (P <
0.01) (Fig. 7); in control14 group islets, the increase appeared
at 8.3 mmol/l glucose (P < 0.05) (Fig. 7). Moreover, Px14
islets showed a significant increase in MTT glucose reduction
at glucose concentrations higher than 5.6 mmol/l (P < 0.01),
and the maximal values were twice those observed in islets
from control14 group. Islets from Px14 group recovered a nor-
mal MTT glucose reduction after 48-h culture in 5.6 mmol/l
glucose (Fig. 7).
D I S C U S S I O N
In this study, we investigated the stimulus-secretion coupling
mechanisms in 60% Px mice, a model in which normo-
glycemia and normolipidemia are maintained despite re-
duced b-cell mass.
The metabolic characteristics and growth of the pancreatic
remnant in 60% Px rats have been well characterized (16), and
we anticipated that the model would have similar character-
istics in mice. The 60% Px mice remained normoglycemic
despite the significant b-cell mass reduction, excluding the
possibility of any transitory hyperglycemia interfering with
changes in glucose sensitivity. In addition, 60% Px mice were
normolipidemic, excluding the possibility that altered plasma
F FA levels led to the observed changes. Furthermore, pro-
gressive b-cell regeneration in the pancreatic remnant pro-
vided an excellent model to investigate the reversibility of
changes in b-cell glucose sensitivity and their relationship with
b-cell mass. Although b-cell mass increased markedly after par-
tial Px, it was still reduced 14 days after Px, at which time 
b-cell glucose sensitivity (insulin secretion, electrical activity,
and [Ca2 +]i) was increased. In contrast, 60 days after Px, b- c e l l
mass increased to 79% of control values and glucose sensitiv-
ity was similar in control and Px60 mice. We suggest that the
increased glucose sensitivity 14 days after Px was an adaptive
response of b-cells to meet the increased metabolic demand
placed on a reduced b-cell mass. The reversibility of this adap-
tive mechanism, shown by the normal glucose sensitivity of the
Px 60 group, was confirmed by the normal glucose sensitivity
observed in Px 14 groups islets after a 48-h culture period.
FIG. 6. Effects of ATP on K+AT P channel activity in inside-out membrane
patches from pancreatic b-cells. A: Representative recordings of chan-
nel activity in a patch exposed to 2.5 and 40 µmol/l AT P, as indicated
above the record, in control14 and Px14 groups. B: Dose-response rela-
tionship for ATP inhibition of KAT P channel activity in pancreatic b- c e l l s
from control14 (s) and Px14 (d) groups. In this figure, the ordinate
represents patch current relative to that in 0 mmol/l ATP (Im a x). The
points show means ± SD, n = 3. Groups are described in M E T H O D S.
FIG. 7. Effect of pancreatectomy on glucose-induced MTT reduction.
Batches of 15 islets from control14 (s), Px14 (d), and Px14 cultured
for 48 h in 5.6 mmol/l glucose (m) groups were incubated for 30 min
at 37°C in 1 ml fresh modified KRB buffer with 1% bovine serum albu-
min, 0.5 mg/ml MTT, and different glucose concentrations. The for-
mation of intracellular MTT-formazan crystals was measured by spec-
trophotometry at 540 nm. All determinations were run in triplicate.
Values are expressed as means ± SE of four experiments. *P < 0 . 0 0 1
compared with control14 group.
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GLUCOSE SUPERSENSITIVITYIN PANCREATECTOMIZED MICE
Increased b-cell sensitivity to glucose has been shown to
precede the loss of glucose-induced insulin secretion in dia-
betic rats and could be the event initiating impaired glucose
potentiation elicited by chronic hyperglycemia (8). However,
glucose supersensitivity has also been found in several nor-
moglycemic conditions characterized by the increased work-
load placed on b-cells. This suggests that hyperglycemia is not
the cause of increased b-cell sensitivity. Changes have been
found in glucokinase, hexokinase, and GLUT2 as islets adapt
to increased metabolic demand, but may not fully account for
the increased glucose sensitivity (27). Recently, we described
an increased b-cell glucose sensitivity in islet cells trans-
planted into diabetic mice that maintained normoglycemia
with a reduced cell b-mass (15). The glucose-induced elec-
trical activity and [Ca2 +]i response in transplanted b- c e l l s
was found to be similar to that found in Px14 b-cells. In that
s t u d y, glucose supersensitivity was attributed to a resting
decrease in the fraction of blockable KAT P channels, which
could be caused by either an increase in the glucose metabolic
modulators of KAT P channels or a change in the properties of
the channel. To address the second possibility, we studied the
input resistance and KAT P channel sensitivity to AT P. No signi-
ficant differences were observed in the input resistances
between b-cells from Px14 and control groups, indicating
that the numbers of KAT P channels were similar for b- c e l l s
from both groups. Finally, patch-clamp studies did not show
any modification of ATP effect on KAT P channels in b-cells from
Px14 mice compared with control mice. Furthermore, Px did
not affect the magnitude of the unitary current. These data,
together with no significant modification in channel activity,
imply that there is no significant change in the open probability.
Glucose metabolism was assessed by the MTT reduction
test. The intracellular reduction of the tetrazolium dye MTT
allows determination of b-cell metabolic activity (26). A very
good correlation has been shown between MTT reduction,
glycolytic flux, glucose oxidation, and insulin secretion in
INS cells and rat islets (26). The MTT reduction experiments
showed a significant displacement to the left of the b- c e l l
oxidative metabolism, with an increased glucose metaboliza-
tion at all glucose concentrations tested (except 2.8 mmol/l
glucose) in islets from the Px14 group. A similar pattern was
observed for insulin release in islets from the Px14 group.
These data suggest that metabolic steps of the stimulus-
secretion coupling mechanism are probably responsible for the
increased glucose sensitivity. An additional role of glucokinase
in this phenomenon cannot be ruled out (12). The enhanced
insulin secretion observed in Px14 islets from 5.6 mmol/l
glucose could also be indicative of augmentation of the Ca2 +-
dependent mechanism of insulin secretion by KAT P c h a n-
nel–independent glucose signaling. In addition, GTP-depen-
dent mechanisms (28) could be involved in the increased
glucose-induced insulin secretion elicited by Px islets.
The results described here show that in b-cells from the
Px14 group, 1) there is a displacement to the left of the glu-
cose dose-response curve and b-cell oxidative metabolism,
with a decrease in the glucose threshold; 2) there is an
increase in the dynamic range of the system in terms of oscil-
latory electrical activity and [Ca2 +]i oscillations; and 3) there
are no modifications in the channel properties of the KAT P
channel. In summary, we have found an increased sensitivity
to glucose for insulin secretion 14 days after 60% Px, during
which time normoglycemia was maintained with a reduced
b-cell mass. b-Cell glucose sensitivity returned to normal
when b-cell mass increased to control mice values, indicat-
ing that the change in sensibility was a reversible adaptive
mechanism in response to the increased workload placed on
b-cells. The lowered glucose set-point was not due to modi-
fication of the KAT P c h a n n e l ’s intrinsic properties. Thus, the
results suggest that increased glucose sensitivity in terms of
insulin secretion, electrical activity, and Ca2 + signaling is
probably due to changes in glucose metabolism.
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